{"id":9420,"date":"2021-04-26T10:00:29","date_gmt":"2021-04-26T17:00:29","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=9420"},"modified":"2021-04-28T10:01:15","modified_gmt":"2021-04-28T17:01:15","slug":"interim-findings-from-first-dose-mass-covid-19-vaccination-roll-out-and-covid-19-hospital-admissions-in-scotland-a-national-prospective-cohort-study","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/04\/26\/interim-findings-from-first-dose-mass-covid-19-vaccination-roll-out-and-covid-19-hospital-admissions-in-scotland-a-national-prospective-cohort-study\/","title":{"rendered":"Interim Findings from First-Dose Mass COVID-19 Vaccination Roll-out and COVID-19 Hospital Admissions in Scotland: A National Prospective Cohort Study"},"content":{"rendered":"<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">B<\/span><span style=\"font-weight: 400\">etween Dec<\/span><span style=\"font-weight: 400\">ember<\/span><span style=\"font-weight: 400\"> 8, 2020, and Feb<\/span><span style=\"font-weight: 400\">ruary<\/span><span style=\"font-weight: 400\"> 22, 2021, receipt of the first dose of the <\/span><span style=\"font-weight: 400\">Pfizer-BioNTech <\/span><span style=\"font-weight: 400\">vaccine in Scotland was associated with a vaccine effectiveness of 91% for reduced COVID-19 hospital admission at 28\u201334 days post-vaccination, and <\/span><span style=\"font-weight: 400\">88% for the Oxford-AstraZeneca <\/span><span style=\"font-weight: 400\">vaccine. Over the study period, a total of 1,331,993 individuals <\/span><span style=\"font-weight: 400\">who had not previously tested positive for SARS-CoV-2 <\/span><span style=\"font-weight: 400\">were vaccinated. <\/span><span style=\"font-weight: 400\">V<\/span><span style=\"font-weight: 400\">accine eff<\/span><span style=\"font-weight: 400\">i<\/span><span style=\"font-weight: 400\">c<\/span><span style=\"font-weight: 400\">acy<\/span><span style=\"font-weight: 400\"> against hospital admission due to COVID-19 w<\/span><span style=\"font-weight: 400\">as<\/span><span style=\"font-weight: 400\"> similar <\/span><span style=\"font-weight: 400\">(83%) <\/span><span style=\"font-weight: 400\">when restricting the analysis to those aged 80 years and older.<\/span><\/li>\n<\/ul>\n<p><i><span style=\"font-weight: 400\">Vasileiou et al.\u00a0(Apr 26, 2021). Interim Findings from First-Dose Mass COVID-19 Vaccination Roll-out and COVID-19 Hospital Admissions in Scotland: A National Prospective Cohort Study. The Lancet. <\/span><\/i><a href=\"https:\/\/doi.org\/10.1016\/S0140-6736(21)00677-2\"><span style=\"font-weight: 400\">https:\/\/doi.org\/10.1016\/S0140-6736(21)00677-2<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Between December 8, 2020, and February 22, 2021, receipt of the first dose of the Pfizer-BioNTech vaccine in Scotland was associated with a vaccine effectiveness of 91% for reduced COVID-19 hospital admission at 28\u201334 days post-vaccination, and 88% for the Oxford-AstraZeneca vaccine. Over the study period, a total of 1,331,993 individuals who had not previously&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/04\/26\/interim-findings-from-first-dose-mass-covid-19-vaccination-roll-out-and-covid-19-hospital-admissions-in-scotland-a-national-prospective-cohort-study\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[147],"topic":[31],"class_list":["post-9420","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-vaccination","topic-vaccines-and-immunity"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9420","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=9420"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9420\/revisions"}],"predecessor-version":[{"id":9421,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9420\/revisions\/9421"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=9420"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=9420"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=9420"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=9420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}